Expression of human ACE2 N-terminal domain, part of the receptor for SARS-CoV-2, in fusion with maltose binding protein, <i>E. coli</i> ribonuclease I and human RNase A

Shuang-yong Xu(New England Biolabs (United States)), Erbay Yigit(New England Biolabs (United States))
bioRxiv (Cold Spring Harbor Laboratory)
February 1, 2021
Cited by 1


Related Papers